Kalaris Therapeutics (KLRS) Other Accumulated Expenses (2019 - 2026)
Kalaris Therapeutics (KLRS) posted Other Accumulated Expenses of $5.9 million for Q2 2026, up 136.2% from $2.5 million a year earlier and up 10.2% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Kalaris Therapeutics' Other Accumulated Expenses came in at $4.3 million, up 551.7% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 90.1% (FY2020 to FY2025).
- In prior years, Kalaris Therapeutics' Other Accumulated Expenses was $659,000 in FY2024 (-36.2%), $1.03 million in FY2023 (+24.8%), $828,000 in FY2022 (-35.8%) and $1.29 million in FY2021 (+645.1%).
- The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2019.
- On a year-over-year basis, Other Accumulated Expenses has increased in each of the last three quarters, with growth averaging 226.4% over the last six quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2021, with growth of 645.1%; the weakest was Q2 2024, with a decline of 88.4%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $5.35 million (Q1 2026), $4.3 million (Q4 2025) and $3.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kalaris Therapeutics | 64.27 Mn | 64.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.90 Mn |
| Mar 31, 2026 | 5.35 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Sep 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 659,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 464,000.00 |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 828,000.00 |
| Sep 30, 2022 | 727,000.00 |
| Jun 30, 2022 | 628,000.00 |
| Mar 31, 2022 | 394,000.00 |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 409,000.00 |
API Access
Kalaris Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();